Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 08/25: (BHP) (FFIV) (AEO) Upgraded; (ECA) (UTHR) (HPQ) Downgraded
-
Maxim Group Downgrades United Therapeutics Corp. (UTHR) to Hold
-
Maxim Group Starts Medgenics (MDGN) at Buy
-
Maxim Group Upgrades E-House (China) Holdings Ltd (EJ) to Hold
-
Maxim Group Maintains a 'Buy' on MakeMyTrip (MMYT); Revenue Beat; Continued Opportunity on Fast-Growing Indian Travel Market
-
Maxim Group Downgrades China Automotive Systems (CAAS) to Hold
-
Maxim Group Upgrades Laboratory Corporation of America (LH) to Buy
-
Maxim Group Reiterates a 'Buy' on Liberty Starz (LSTZA); Positive Subscriber and Cash Flow Increase; Raising 2011/12 Estimates
-
Maxim Group Reiterates a 'Buy' on Carmike Cinemas (CKEC); Strong 2Q11 Results – Finally a Positive Surprise
-
Maxim Group Maintains a 'Buy' on Live Nation (LYV); Q2 A Positive Surprise
-
Q2 Preview: Sub Losses Starting to Ebb for Comcast (CMCSA); Analysts Expect More Upside
-
Maxim Group Comments on Comcast (CMCSA) Ahead of Earnings, Sees 5.5% Video Subscriber Growth
-
Maxim Group Boosts Price Target On Carmike Cinemas (CKEC) to $13
-
Notable Analyst Rating Changes 08/01: (RSH) (ACI) (SPF) Upgraded; (SUNH) (KND) (BCSI) Downgraded
-
Maxim Group Starts Renren Inc (RENN) at Sell
-
NeoStem (NBS) Closes 13.75M Unit Offering at $1.20/Unit
-
Maxim Group Upgrades Express Scripts (ESRX) to Buy
-
Maxim Still Rates Yoku.com (YOKU) at Sell, Competition Kills Growth Potential
-
Maxim Group Maintains Bullish Stance On Pandora (P) Following Analyst Day
-
Pandora (P) Analyst Day Will Help Answer Some Questions
-
Notable Analyst Rating Changes 07/01: (NTAP) (MUR) (VRTS) Upgraded; (AMCX) (DAR) (RVBD) Downgraded
-
TiVo (TIVO) Higher On Takeover Speculation
-
Maxim Group Downgrades AMC Networks (AMCX) to Hold; Valuation Call
-
Pandora (P) Plans to Double-Dip Wall Street as Quiet Period Expires
-
Maxim Group Starts STR Holdings (STRI) at Buy, Sees Opportunity Where Others May Fall
-
Maxim Group Starts Yingli Green Energy (YGE) at Hold, $8 Price Target
-
Maxim Group Starts Suntech Power (STP) at Sell, Not Sustainable
-
Maxim Starts Solar Stocks: TSL, STRI at Buy, YGE at Hold, FSLR, STP at Sell
-
Maxim Starts Affymetrix (AFFX), Illumina (ILMN) at Buy, Life Tech (LIFE), Pacific Bio (PACB) at Hold
-
Maxim Starts Pandora (P) at Buy, Sets $23 Price Target
-
Maxim Group Downgrades China Ming Yang Wind Power (MY) to Hold
-
Nautilus Marine Acquisition (NMAR) Files $60M IPO
-
Maxim Group Downgrades China-Biotics (CHBT) to Sell
-
Maxim Cuts E-House (China) Holdings (EJ) to Sell; Sees 13% Downside
-
Brainsway (BRIN) Sees IPO Price of $9 - $11/Share and Warrant
-
Maxim Group Upgrades Sony Corp. (SNE) to Buy
-
Maxim Group Starts Cablevision (CVC) at Buy
-
Maxim Group Downgrades Wonder Auto Technology (WATG) to Hold
-
Maxim Group Upgrades Rovi Corp. (ROVI) to Buy
-
Maxim Group Upgrades Woodward (WWD) to Buy
-
Maxim Group Upgrades Hemispherx (HEB) to Buy
-
Maxim Group Upgrades Netflix (NFLX) to Hold
-
Maxim Group Upgrades A.O. Smith (AOS) to Buy
-
Maxim Group Downgrades Madison Square Garden (MSG) to Hold
-
Maxim Group Starts Onyx Pharmaceuticals (ONXX) at Buy
-
Maxim Group Downgrades Sony Corp. (SNE) to Hold
-
Brainsway Ltd. (BRIN) Files $30M IPO
-
Maxim Group Upgrades LCA-Vision (LCAV) to Buy
-
Maxim Group Starts Varian Medical (VAR) at Buy
-
Maxim Cuts SORL Auto Parts (SORL) to Hold

